Results 131 to 140 of about 65,094 (251)
International Journal of Eating Disorders, EarlyView.ABSTRACT Objective Emerging evidence indicates that experiencing discrimination is associated with disordered eating. This study aimed to test the association between experiences of colorism (skin shade discrimination penalizing those with darker skin) and the prevalence of disordered weight control behaviors (DWCBs) in four Asian countries/regions ...
Nadia Craddock +5 more
wiley +1 more source
Safe and Sound: Is Safeness a Specific Affective Dimension Related to Eating Disorder Behaviors?
International Journal of Eating Disorders, EarlyView.ABSTRACT Objective Safeness is a warm, soothing emotional state that is often experienced in the presence of close others. Safeness is thought to be distinct from other positive emotions or the absence of negative emotions and is shown to predict mental health variables over and above other emotions.
Ege Bicaker +3 more
wiley +1 more source
International Journal of Eating Disorders, EarlyView.ABSTRACT Objective This Stage 2 Registered Report examined (1) the main effects and interaction of within‐person daily associations between ovarian hormones (i.e., estrogen, progesterone) and loss of control eating (LOCE), and (2) the within‐person mediating roles of food‐related reward anticipation and response inhibition. Methods Adolescent girls (n =
Tyler B. Mason +4 more
wiley +1 more source
Bayesian Structure Learning for Dynamic Brain Connectivity. [PDF]
, 2018 Peer ...
Michael Riis Andersen +4 more
openaire +2 more sources
A phenomap of TTR amyloidosis to aid diagnostic screening
ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos +4 more
wiley +1 more source
Epilepsia, EarlyView.Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin +7 more
wiley +1 more source
The Bayesian brain: What is it and do humans have it? [PDF]
Behav Brain Sci, 2019 Rahnev D.
europepmc +1 more source
Epilepsia, EarlyView.Abstract Objective This cohort study examined the agreement between youth‐ and parent‐reported health‐related quality of life (HRQOL) of children treated with epilepsy surgery compared to medical therapy. A second aim was to evaluate whether changes in HRQOL over 2 years differed between the two groups, and to determine whether these trajectories ...
Mary Lou Smith +2 more
wiley +1 more source
Artificial intelligence for adaptive neuromodulation in drug‐resistant epilepsy
Epilepsia, EarlyView.Abstract Drug‐resistant epilepsy (DRE) affects nearly one third of people with epilepsy and is associated with substantial cognitive, psychiatric, and mortality burdens. For patients who are not candidates for resection or laser interstitial thermal therapy, neuromodulation therapies such as vagus nerve stimulation, deep brain stimulation, and ...
Amir Hossein Daraie +10 more
wiley +1 more source
An n‐of‐1 gene‐directed drug repurposing trial for an ultrarare genetic condition
Epilepsia, EarlyView.Abstract Objective Gain‐of‐function (GoF) variants in the KCNC1 potassium channel subunit gene (Kv3.1) cause motor/cognitive delays and hypotonia and have been associated with seizures. Fluoxetine has inhibitory effects on Kv3.1. However, open‐label nonrandomized administration is insufficient to guide clinical decision‐making in ultrarare conditions ...
Vedika Jha +13 more
wiley +1 more source